Stay updated on Pembrolizumab and TKI in CML MRD Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and TKI in CML MRD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and TKI in CML MRD Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Recent changes are administrative updates to the study record dates (December 2025 and November 2025). They do not modify core study information such as eligibility, interventions, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-06T16:39:14.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    Locations section added and lists study sites by state (Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Idaho, Illinois, Iowa, Kansas, Kentucky, Maryland, Michigan, Minnesota, Missouri, Montana, Nebraska, New Jersey, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Virginia, Washington, West Virginia, Wisconsin, Wyoming) with Revision: v3.3.3. Per-state location subsections were removed, the HHS Vulnerability Disclosure link was removed, and the revision updated from v3.3.2.
    Difference
    1.0%
    Check dated 2025-12-23T08:38:24.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    The page shows a new Revision: v3.3.2 added and a Revision: v3.3.1 removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T16:42:39.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.1.
    Difference
    0.0%
    Check dated 2025-11-24T11:09:51.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Recent update dates (2025-11-11 and 2025-11-13) appear on the study page, and an older funding notice was removed. These are maintenance updates that do not alter study content or results; to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-16T05:59:48.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    Updates to the study record history show new Last Update posts dated 2025-10-29 and 2025-10-28, with removals of September entries. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-02T00:17:43.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and TKI in CML MRD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and TKI in CML MRD Clinical Trial page.